Cargando…

NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in Very Low-Birth-Weight Infants

PURPOSE: A hemodynamically significant Patent ductus arteriosus (HsPDA) in premature infants is known to be associated with significant morbidity. Recently brain natriuretic peptides and superior mesenteric artery (SMA)-resistive indices have been used to effectively diagnose HsPDA. OBJECTIVE: To as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buddhe, Sujatha, Dhuper, Sarita, Kim, Roger, Weichbrod, Laya, Mahdi, Eman, Shah, Nishant, Kona, Sashi, Sokal, Myron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743145/ https://www.ncbi.nlm.nih.gov/pubmed/24027696 http://dx.doi.org/10.4103/2249-4847.96758

Ejemplares similares

Exploring the NT-proBNP expression in Premature Infants with Patent Ductus Arteriosus (PDA) by Echocardiography
por: Shi, Yunlong, et al.
Publicado: (2021)

Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial
por: Potsiurko, Solomiia, et al.
Publicado: (2021)

Gentamicin in Neonates with Hemodynamically Significant Patent Ductus Arteriosus
por: Sridharan, Kannan, et al.
Publicado: (2023)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Case of Patent Ductus Arteriosus
por: Harrington, Archibald W.
Publicado: (1914)

The Wide Patent Ductus Arteriosus
por: Aitken, G. J.
Publicado: (1955)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

In Utero Diagnosis of Agenesis of the Ductus Arteriosus in a Twin Pregnancy: An Unusual Case Presentation
por: Gaither, Kecia, et al.
Publicado: (2011)

Patent Ductus Arteriosus Device Embolization
por: Iqbal, K, et al.
Publicado: (2011)

Pharmacological closure of the patent ductus arteriosus
por: Mehta, SK, et al.
Publicado: (2003)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Comparison of effectiveness and cost of patent ductus arteriosus device occlusion versus surgical ligation of patent ductus arteriosus
por: Zulqarnain, Arif, et al.
Publicado: (2016)

Percutaneous closure of patent ductus arteriosus with the Nit-Occlud(®) patent ductus arteriosus device in 268 consecutive cases
por: Maksymenko, Andrii V, et al.
Publicado: (2019)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Change and clinical significance of serum cortisol, BNP, and PGE-2 levels in premature infants with patent ductus arteriosus
por: Cui, Qintao, et al.
Publicado: (2021)

Flipper coil closure of patent ductus arteriosus
por: Grech, V, et al.
Publicado: (2007)

Coil Occlusion of the Large Patent Ductus Arteriosus
por: Kumar, RK, et al.
Publicado: (2008)

Thoracoscopic closure of patent ductus arteriosus in children
por: Kołtowski, P, et al.
Publicado: (2013)

Large patent ductus arteriosus: To close or not to close
por: Tharakan, Jaganmohan, et al.
Publicado: (2012)

A rare association with patent ductus arteriosus
por: Warrier, Dhanya, et al.
Publicado: (2012)

Surgical treatment of patent ductus arteriosus in neonates
por: Almeida, Rui, et al.
Publicado: (2015)

Aneurysm of the Pulmonary Artery with Patent Ductus Arteriosus
por: Subramaniam, R.
Publicado: (1947)

Patent Ductus Arteriosus and Its Surgical Treatment
por: Mercer, Walter
Publicado: (1946)

Anesthetic management of patent ductus arteriosus in adults
por: Shinde, Shital Rajesh, et al.
Publicado: (2016)

Transcatheter closure of patent ductus arteriosus in adults
por: Mori, Yoshiki
Publicado: (2013)

Patent Ductus Arteriosus Mimicking Hypertrophic Cardiomyopathy
por: Khajali, Zahra, et al.
Publicado: (2021)

When to Treat Hemodynamically Insignificant Patent Ductus Arteriosus in Preterm Infants
por: Al-Abdi, Sameer Y.
Publicado: (2012)

The Hemodynamics of Patent Ductus Arteriosus in Patients after Central Shunt Operation
por: Xu, Pan, et al.
Publicado: (2021)

Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_96g5bc33sdnsffb9eci6dtamqs